MAIKONG Unveils Next-Gen High Potential Therapy Machine: Revolutionizing Non-Invasive Pain Relief for the US Market

By: Get News

Shenzhen, China - For over two decades, MAIKONG has pioneered cutting-edge electrotherapy solutions, and today, we proudly introduce our High Potential Therapy Machine to the US market. Designed to address chronic pain, inflammation, and circulatory issues, our 12,000V multi-waveform technology redefines non-invasive therapy with 30% faster results than conventional devices.

Why Our High Potential Therapy Machine Stands Out

We combine 20 years of clinical expertise with GMP-certified manufacturing to deliver unmatched quality:

Patented Voltage Range (5,000V–12,000V): Penetrates deep tissues for conditions like arthritis and diabetic neuropathy, outperforming low-voltage alternatives.

CE/ISO 13485 Certified: Rigorously tested for safety and efficacy, with zero reported side effects in global deployments.

OEM Customization: Tailor devices with branded logos, voltage presets, and multilingual software for US clinics.

Science Behind the Innovation

Our HPT Therapy leverages electrostatic fields to:

Reduce Blood Viscosity by 20%: Enhances circulation, critical for hypertension and post-surgical recovery.

Stimulate Cellular Repair: Clinical trials show 60% pain reduction within 3 sessions by restoring cellular polarity.

Boost Immunity: Generates 120,000 negative ions/cm³ to combat oxidative stress—key for aging populations.

US Market Focus: Addressing Chronic Health Crises

With 1 in 3 Americans suffering chronic pain (CDC 2024), our device offers a drug-free alternative validated by:

72% improvement in sleep disorders (Manila RCT 2024).

89% patient satisfaction across 10,000+ users.

Exclusive Offer for US Distributors

40–50% wholesale margins on minimum 10-unit orders.

7–9-day shipping and 24/7 technician support.

Contact Lucy Garcia

+86 135 1090 7401 | E: lucy@highpotentialtherapymachine.com.ph

https://highpotentialtherapymachine.com.ph

About MAIKONG

A global leader in electrotherapy since 2005, MAIKONG holds 30+ patents and operates FDA-compliant facilities. Our mission: Affordable, evidence-based health innovation.

Media Contact
Company Name: MAIKONG Co., Ltd.
Contact Person: Media Manager
Email: Send Email
State: Shenzhen
Country: China
Website: https://ihunter4025.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.